Neurosense Historical Income Statement

NRSN Stock  USD 0.86  0.07  7.53%   
Historical analysis of Neurosense Therapeutics income statement accounts such as Selling General Administrative of 3.3 M can show how well Neurosense Therapeutics performed in making a profits. Evaluating Neurosense Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Neurosense Therapeutics's future profits or losses.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.

About Neurosense Income Statement Analysis

Neurosense Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Neurosense Therapeutics shareholders. The income statement also shows Neurosense investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Neurosense Therapeutics Income Statement Chart

At this time, Neurosense Therapeutics' Interest Income is very stable compared to the past year. As of the 15th of December 2024, Depreciation And Amortization is likely to grow to about 101.8 K, while Net Interest Income is likely to drop (390.6 K).

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Neurosense Therapeutics. It is also known as Neurosense Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Neurosense Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Neurosense Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.At this time, Neurosense Therapeutics' Interest Income is very stable compared to the past year. As of the 15th of December 2024, Depreciation And Amortization is likely to grow to about 101.8 K, while Net Interest Income is likely to drop (390.6 K).

Neurosense Therapeutics income statement Correlations

-0.19-0.3-0.99-0.32-0.350.380.320.22-0.370.22-0.350.32-0.770.240.650.2-0.160.33
-0.190.930.260.690.74-0.85-0.88-0.850.83-0.850.74-0.880.45-0.890.05-0.930.85-0.88
-0.30.930.380.90.92-0.98-0.99-0.980.95-0.980.92-0.990.69-0.99-0.28-0.990.94-0.76
-0.990.260.380.40.43-0.45-0.4-0.310.48-0.310.43-0.40.8-0.32-0.65-0.290.26-0.35
-0.320.690.90.40.99-0.96-0.95-0.960.94-0.960.99-0.950.82-0.94-0.58-0.890.93-0.43
-0.350.740.920.430.99-0.98-0.97-0.970.97-0.971.0-0.970.82-0.96-0.56-0.90.94-0.47
0.38-0.85-0.98-0.45-0.96-0.981.00.99-0.970.99-0.981.0-0.80.990.450.96-0.940.65
0.32-0.88-0.99-0.4-0.95-0.971.00.99-0.970.99-0.971.0-0.751.00.390.98-0.960.67
0.22-0.85-0.98-0.31-0.96-0.970.990.99-0.951.0-0.970.99-0.711.00.370.97-0.960.62
-0.370.830.950.480.940.97-0.97-0.97-0.95-0.950.97-0.970.77-0.96-0.43-0.920.95-0.56
0.22-0.85-0.98-0.31-0.96-0.970.990.991.0-0.95-0.970.99-0.711.00.370.97-0.960.62
-0.350.740.920.430.991.0-0.98-0.97-0.970.97-0.97-0.970.82-0.96-0.56-0.90.94-0.47
0.32-0.88-0.99-0.4-0.95-0.971.01.00.99-0.970.99-0.97-0.751.00.390.98-0.960.67
-0.770.450.690.80.820.82-0.8-0.75-0.710.77-0.710.82-0.75-0.69-0.86-0.620.62-0.36
0.24-0.89-0.99-0.32-0.94-0.960.991.01.0-0.961.0-0.961.0-0.690.320.98-0.960.67
0.650.05-0.28-0.65-0.58-0.560.450.390.37-0.430.37-0.560.39-0.860.320.2-0.26-0.14
0.2-0.93-0.99-0.29-0.89-0.90.960.980.97-0.920.97-0.90.98-0.620.980.2-0.970.75
-0.160.850.940.260.930.94-0.94-0.96-0.960.95-0.960.94-0.960.62-0.96-0.26-0.97-0.57
0.33-0.88-0.76-0.35-0.43-0.470.650.670.62-0.560.62-0.470.67-0.360.67-0.140.75-0.57
Click cells to compare fundamentals

Neurosense Therapeutics Account Relationship Matchups

Pair Trading with Neurosense Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neurosense Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Neurosense Stock

  0.72VALN Valneva SE ADRPairCorr
  0.79ERNA Eterna TherapeuticsPairCorr

Moving against Neurosense Stock

  0.75DYAI Dyadic InternationalPairCorr
  0.55ESPR Esperion TherapeuticsPairCorr
  0.55BMY Bristol Myers SquibbPairCorr
  0.36DNA Ginkgo Bioworks HoldingsPairCorr
  0.33FLGC Flora Growth CorpPairCorr
The ability to find closely correlated positions to Neurosense Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neurosense Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neurosense Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neurosense Therapeutics to buy it.
The correlation of Neurosense Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurosense Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurosense Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neurosense Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Neurosense Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurosense Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurosense Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurosense Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Return On Assets
(1.51)
Return On Equity
(4.95)
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.